Two interventions have a strong evidence base and should, in my view, be part of every GLP-1 treatment discussion
Like Ozempic, many of these medications may also help reduce the risk of weight-related health conditions, like heart disease
Realistic expectations What Lipo-C can do: Enhance fat burning when combined with caloric deficit, boost energy levels during weight loss, support liver function and metabolic efficiency, help preserve muscle mass during dieting, complement GLP-1 medications for enhanced results
Our experienced medical providers carefully evaluate each patients medical history, treatment goals, preferences, and potential side effects when recommending the most suitable GLP-1 receptor agonist
Cyclical, not continuous use breaks between cycles limit exposure to the TMA/TMAO pathway and allow for the assessment of the baseline effect
SURMOUNT-1 results (72 weeks, adults with obesity): 5 mg dose: approximately 15% body weight loss 10 mg dose: 19.5% body weight loss 15 mg dose: 22.5% body weight loss Placebo: 3.1% body weight loss At the 15 mg maximum dose, the average participant lost about 52 pounds over 72 weeks